It is a pharma private limited company based in New Delhi, Delhi, India, established in 2007.
2007 | New Delhi, Delhi, India | ActiveStaywell Formulation Private Limited, a active private limited company, was established on 20 November 2007 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233DL2007PTC170595. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.84 Cr.
It upholds a compliant status. Employing 32 professional, Its leadership includes Suresh Lal Santuka (Director), Vikash Kumar Santuka (Director). Past directors included Surendra Singh Pokhariyal, Sidharatha Bansal, Ruchi Tyagi. It holds ₹11.80 Cr open charges and ₹6.60 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at First Floor, 14, Rani Jhansi Road, New Delhi, Delhi, 110055.
U24233DL2007PTC170595
170595
20 November 2007
₹3.00 Cr
₹2.84 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Staywell Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Lal Santuka | Director | 21 Dec 2015 | Current |
| Vikash Kumar Santuka | Director | 21 Dec 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Jun 2023 | Past |
| Pramod Abcsdd | Director | 30 Sep 2011 | Past |
| Pramod Abcsdd | Director | 06 Jun 2023 | Past |
| Pramod Abcsdd | Director | 31 Mar 2019 | Past |
| Pramod Abcsdd | Director | 20 Aug 2013 | Past |
| Pramod Abcsdd | Director | 25 Oct 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Staywell Formulation Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.24% increase. The company also saw a substantial fall in profitability, with a 2810.17% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Staywell Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹118,036,000.00
₹66,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2012 | Dena Bank | ₹11.80 Cr | Open |
| 27 Mar 2010 | Canara Bank | ₹8.00 M | Satisfied |
| 30 Mar 2009 | Canara Bank | ₹3.30 Cr | Satisfied |
| 30 Mar 2009 | Canara Bank | ₹5.00 M | Satisfied |
| 30 Mar 2009 | Canara Bank | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Staywell Formulation has a workforce of 32 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Staywell Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Staywell Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Staywell Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Staywell Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Suresh Lal Santuka was appointed as a Director was appointed as a Director on 21 Dec 2015 & has been associated with this company since 9 years 11 months . was documented.
The activity Vikash Kumar Santuka was appointed as a Director was appointed as a Director on 21 Dec 2015 & has been associated with this company since 9 years 11 months . was completed.
Progress on A charge with Dena Bank of Rs. 11.80 Cr registered on 19 Mar 2012 with Charge ID 10347346 was modified on 30 Dec 2014. was documented.
The activity A charge registered on 27 Mar 2010 via Charge ID 10220401 with Canara Bank was fully satisfied on 22 Apr 2013. was completed.
The CIN of Staywell Formulation Private Limited is U24233DL2007PTC170595.
Staywell Formulation Private Limited is headquartered at First Floor, 14, Rani Jhansi Road, New Delhi, Delhi, 110055.
Staywell Formulation Private Limited was incorporated on 20 November 2007.
The current directors of Staywell Formulation Private Limited are
The primary industry of Staywell Formulation Private Limited is Manufacturing.
Staywell Formulation Private Limited is unlisted.
The authorized capital of Staywell Formulation Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.84 Cr.
The compliance status of Staywell Formulation Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX